Stock Market Update from Briefing.com29 Jul 2014, 2:50 pmStock Market Update from Briefing.com
Active Strategies Continue to Lag Passive Index ETFs29 Jul 2014, 6:00 amWhen picking an actively managed fund, people are betting on the fund manager’s ability to produce alpha, or outperformance. However, investors may be better served in a passive index-based exchange traded ...
Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox18 Jul 2014, 12:32 pmBiotech columnist Adam Feuerstein answers readers' questions about health care companies. Click to view a price quote on ACRX . Click to research the Conglomerates industry.
Must-know: 2 stock market segments offering good value17 Jul 2014, 11:15 amEquities in the more expensive market segments are particularly vulnerable.
The Zacks Analyst Blog Highlights: Intel, Yahoo, CSX, Global X Social Media Index ETF and iShares Nasdaq Biotechnology ...16 Jul 2014, 6:11 amThe Zacks Analyst Blog Highlights: Intel, Yahoo, CSX, Global X Social Media Index ETF and iShares Nasdaq Biotechnology ETF
Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation15 Jul 2014, 1:29 pmNEW YORK (TheStreet) -- Much of the Federal Reserve's report on monetary policy was overlooked on Tuesday with most of the attention focused on Chair Janet Yellen's comments that some sectors of the markets, notably biotech and social media, were overvalued. In prepared remarks, Yellen told the Senate Banking Committee she saw certain sectors as "substantially stretched," sending shares tumbling ...
Fed Says Social Media Stock Valuations Appear ‘Stretched’15 Jul 2014, 10:29 amThe Federal Reserve said valuations of social media and biotechnology shares appear to be “stretched,” even as stock valuations overall remain close to historical norms.
Stock Market Today: Biotech, Social Media Stocks Slide Following Yellen's Remarks15 Jul 2014, 8:06 amNEW YORK (TheStreet) -- Major U.S. stock markets tumbled Tuesday following Federal Reserve Chair Janet Yellen's prepared remarks to the Senate Banking Committee that some sectors of the markets, notably biotech and social media, appear overvalued. The iShares Nasdaq Biotechnology Index ETF slid 2.6% on the remarks, as MannKind dropped 1.7%, Geron moved 5% lower, and Ariad Pharmaceuticals was ...
Did someone say bubble? Stocks pull back15 Jul 2014, 8:01 amA new report from the Fed suggests social media and bio tech stocks might be overvalued.
Market Snapshot: Momentum plays pull down U.S. stock market15 Jul 2014, 4:28 amThe U.S. stock market closes lower, dragged down by sharp declines in momentum stocks after the Federal Reserve suggested valuations on biotech and Internet stocks may be stretched.